<b><i>Background:</i></b> <i>Serratia marcescens</i> may cause severe nosocomial infections, mostly in very low birth weight infants. Since <i>S. marcescens</i> exhibits by far the highest adjusted incidence rate for horizontal transmission, it can cause complex outbreak situations in neonatal intensive care units. <b><i>Objective:</i></b> The aim of this study was to establish a fast and highly sensitive colonization screening for prompt cohorting and barrier nursing strategies. <b><i>Methods:</i></b> A probe-based duplex PCR assay targeting the 16S <i>rRNA</i> gene of <i>S. marcescens</i> was developed and validated by using 36 reference strains, 14 <i>S. marcescens</i> outbreak- and nonoutbreak isolates, defined by epidemiological linkage and molecular typing, and applied in 1,347 clinical specimens from 505 patients. <b><i>Results and Conclusions:</i></b> The novel PCR assay proved to be highly specific and had an in vitro sensitivity of 100 gene copies per reaction (∼15 bacteria). It showed a similar (in laryngeal/tracheal specimens) or even higher (in rectal/stoma swabs) in vivo sensitivity in comparison to routine microbial culture and was much quicker (<24 h vs. 2 days). By combining different oligonucleotide primers, there was robust detection of genetic variants of <i>S. marcescens</i> strains. PCR inhibition was low (1.6%) and observed with rectal swabs only. Cohort analysis illustrated applicability of the PCR assay as a quick tool to prevent outbreak scenarios by allowing rapid decisions on cohorting and barrier nursing. In summary, this novel molecular screening for colonization by <i>S. marcescens</i> is specific, highly sensitive, and substantially accelerates detection.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.